[1]
Alzebari, A.M., Qadir, A.M. , Rafaat, M.S. and Salihi, A. 2023. Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy. BioMed Target Journal. 1, 2 (Dec. 2023), 2–21. DOI:https://doi.org/10.59786/bmtj.122.